Abstract
HIV remains incurable due to the existence of a reservoir of cells that harbor intact integrated genomes of the virus in the absence of viral replication. This population of infected cells remains invisible to the immune system and is not targeted by the drugs used in the current antiretroviral therapies (cART). Reversal of latency by the use of inhibitors of chromatin-remodeling enzymes has been studied extensively in an attempt to purge this reservoir of latent HIV but has thus far not shown any success in clinical trials. The full complexity of latent HIV infection has still not been appreciated, and the gaps in knowledge prevent development of adequate small-molecule compounds that can effectively perturb this reservoir. In this review, we will examine the role of epigenetic silencing of HIV transcription, posttranscriptional regulation, and mRNA processing in promoting HIV-1 latency.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adelman K, Lis JT (2012) Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13(10):720–731. https://doi.org/10.1038/nrg3293
Ahluwalia JK, Khan SZ, Soni K, Rawat P, Gupta A, Hariharan M, Scaria V, Lalwani M, Pillai B, Mitra D, Brahmachari SK (2008) Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5:117. https://doi.org/10.1186/1742-4690-5-117
Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM (2001) NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol Cell 8(2):327–337
Bennasser Y, Le SY, Yeung ML, Jeang KT (2004) HIV-1 encoded candidate micro-RNAs and their cellular targets. Retrovirology 1:43
Besnard E, Hakre S, Kampmann M, Lim HW, Hosmane NN, Martin A, Bassik MC, Verschueren E, Battivelli E, Chan J, Svensson JP, Gramatica A, Conrad RJ, Ott M, Greene WC, Krogan NJ, Siliciano RF, Weissman JS, Verdin E (2016) The mTOR complex controls HIV latency. Cell Host Microbe 20(6):785–797. https://doi.org/10.1016/j.chom.2016.11.001
Bignami F, Pilotti E, Bertoncelli L, Ronzi P, Gulli M, Marmiroli N, Magnani G, Pinti M, Lopalco L, Mussini C, Ruotolo R, Galli M, Cossarizza A, Casoli C (2012) Stable changes in CD4+ T lymphocyte miRNA expression after exposure to HIV-1. Blood 119(26):6259–6267
Bjur E, Larsson O, Yurchenko E, Zheng L, Gandin V, Topisirovic I, Li S, Wagner CR, Sonenberg N, Piccirillo CA (2013) Distinct translational control in CD4+ T cell subsets. PLoS Genet 9(5):e1003494. https://doi.org/10.1371/journal.pgen.1003494
Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, Verdin E, Olive D, Van Lint C, Hejnar J, Hirsch I (2009) CpG methylation controls reactivation of HIV from latency. PLoS Pathog 5(8):e1000554. https://doi.org/10.1371/journal.ppat.1000554
Budhiraja S, Famiglietti M, Bosque A, Planelles V, Rice AP (2013) Cyclin T1 and CDK9 T-loop phosphorylation are downregulated during establishment of HIV-1 latency in primary resting memory CD4+ T cells. J Virol 87(2):1211–1220. https://doi.org/10.1128/JVI.02413-12
Bullen CK, Laird GM, Durand CM, Siliciano JD, Siliciano RF (2014) New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo. Nat Med 20(4):425–429. https://doi.org/10.1038/nm.3489
Capelson M, Doucet C, Hetzer MW (2010) Nuclear pore complexes: guardians of the nuclear genome. Cold Spring Harb Symp Quant Biol 75:585–597. https://doi.org/10.1101/sqb.2010.75.059
Cary DC, Fujinaga K, Peterlin BM (2016) Molecular mechanisms of HIV latency. J Clin Invest 126:1–7. https://doi.org/10.1172/JCI80565
Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O (2013) CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci U S A 110(31):12655–12660. https://doi.org/10.1073/pnas.1220136110
Chiang K, Rice AP (2012) MicroRNA-mediated restriction of HIV-1 in resting CD4+ T cells and monocytes. Viruses 4(9):1390–1409. https://doi.org/10.3390/v4091390
Chiang K, Sung TL, Rice AP (2012) Regulation of cyclin T1 and HIV-1 replication by microRNAs in resting CD4+ T lymphocytes. J Virol 86(6):3244–3252. https://doi.org/10.1128/JVI.05065-11
Ciuffi A, Llano M, Poeschla E, Hoffmann C, Leipzig J, Shinn P, Ecker JR, Bushman F (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11(12):1287–1289. https://doi.org/10.1038/nm1329
Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, Hahn BH, Czartoski JL, McElrath MJ, Lehmann C, Klein F, Caskey M, Walker BD, Siliciano JD, Siliciano RF, Jankovic M, Nussenzweig MC (2015) HIV-1 integration landscape during latent and active infection. Cell 160(3):420–432. https://doi.org/10.1016/j.cell.2015.01.020
Coley W, Van Duyne R, Carpio L, Guendel I, Kehn-Hall K, Chevalier S, Narayanan A, Luu T, Lee N, Klase Z, Kashanchi F (2010) Absence of DICER in monocytes and its regulation by HIV-1. J Biol Chem 285 (42):31930–31943
Colin L, Van Lint C (2009) Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies. Retrovirology 6:111. https://doi.org/10.1186/1742-4690-6-111
Colin L, Dekoninck A, Reichert M, Calao M, Merimi M, Van den Broeke A, Vierendeel V, Cleuter Y, Burny A, Rohr O, Van Lint C (2011a) Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation. Nucleic Acids Res 39(22):9559–9573
Colin L, Vandenhoudt N, de Walque S, Van Driessche B, Bergamaschi A, Martinelli V, Cherrier T, Vanhulle C, Guiguen A, David A, Burny A, Herbein G, Pancino G, Rohr O, Van Lint C (2011b) The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PLoS One 6(4):e19084
Darcis G, Van Driessche B, Van Lint C (2017) HIV latency: should we shock or lock? Trends Immunol 38(3):217–228. https://doi.org/10.1016/j.it.2016.12.003
Ding D, Qu X, Li L, Zhou X, Liu S, Lin S, Wang P, Liu S, Kong C, Wang X, Liu L, Zhu H (2013) Involvement of histone methyltransferase GLP in HIV-1 latency through catalysis of H3K9 dimethylation. Virology 440(2):182–189. https://doi.org/10.1016/j.virol.2013.02.022
Doucas V, Tini M, Egan DA, Evans RM (1999) Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. Proc Natl Acad Sci U S A 96(6):2627–2632
du Chene I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia C, Mettling C, Baillat V, Reynes J, Corbeau P, Bertrand E, Marcello A, Emiliani S, Kiernan R, Benkirane M (2007) Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J 26(2):424–435
Duverger A, Wolschendorf F, Zhang M, Wagner F, Hatcher B, Jones J, Cron RQ, van der Sluis RM, Jeeninga RE, Berkhout B, Kutsch O (2013) An AP-1 binding site in the enhancer/core element of the HIV-1 promoter controls the ability of HIV-1 to establish latent infection. J Virol 87(4):2264–2277. https://doi.org/10.1128/JVI.01594-12
Friedman J, Cho WK, Chu CK, Keedy KS, Archin NM, Margolis DM, Karn J (2011) Epigenetic silencing of HIV-1 by the histone H3 lysine 27 methyltransferase enhancer of Zeste 2. J Virol 85(17):9078–9089. https://doi.org/10.1128/JVI.00836-11
Goffin V, Demonte D, Vanhulle C, de Walque S, de Launoit Y, Burny A, Collette Y, Van Lint C (2005) Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res 33(13):4285–4310
Haaland RE, Herrmann CH, Rice AP (2003) Increased association of 7SK snRNA with tat cofactor P-TEFb following activation of peripheral blood lymphocytes. AIDS 17(17):2429–2436. https://doi.org/10.1097/00002030-200311210-00004
Han Y, Lin YB, An W, Xu J, Yang HC, O’Connell K, Dordai D, Boeke JD, Siliciano JD, Siliciano RF (2008) Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4(2):134–146. https://doi.org/10.1016/j.chom.2008.06.008
Hayes AM, Qian S, Yu L, Boris-Lawrie A (2011) Tat RNA silencing suppressor activity contributes to perturbation of lymphocyte miRNA by HIV-1. Retrovirology 8(36):36. https://doi.org/10.1186/1742-4690-8-36
Hnilicova J, Hozeifi S, Duskova E, Icha J, Tomankova T, Stanek D (2011) Histone deacetylase activity modulates alternative splicing. PLoS One 6(2):e16727. https://doi.org/10.1371/journal.pone.0016727
Houzet L, Yeung ML, de Lame V, Desai D, Smith SM, Jeang KT (2008) MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5:118
Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H (2007) Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat Med 13(10):1241–1247. https://doi.org/10.1038/nm1639
Imai K, Togami H, Okamoto T (2010) Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285(22):16538–16545. https://doi.org/10.1074/jbc.M110.103531
Imamichi H, Dewar RL, Adelsberger JW, Rehm CA, O’Doherty U, Paxinos EE, Fauci AS, Lane HC (2016) Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc Natl Acad Sci U S A 113(31):8783–8788. https://doi.org/10.1073/pnas.1609057113
Jadlowsky JK, Wong JY, Graham AC, Dobrowolski C, Devor RL, Adams MD, Fujinaga K, Karn J (2014) Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat. Mol Cell Biol 34(11):1911–1928. https://doi.org/10.1128/MCB.01013-13
Jordan A, Defechereux P, Verdin E (2001) The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J 20(7):1726–1738
Jordan A, Bisgrove D, Verdin E (2003) HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J 22(8):1868–1877
Karn J, Stoltzfus CM (2012) Transcriptional and posttranscriptional regulation of HIV-1 gene expression. Cold Spring Harb Perspect Med 2(2):a006916. https://doi.org/10.1101/cshperspect.a006916
Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E (2009) Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog 5(6):e1000495. https://doi.org/10.1371/journal.ppat.1000495
Khan SZ, Hand N, Zeichner SL (2015) Apoptosis-induced activation of HIV-1 in latently infected cell lines. Retrovirology 12:42. https://doi.org/10.1186/s12977-015-0169-1
Khoury G, Mota TM, Li S, Tumpach C, Lee MY, Jacobson J, Harty L, Anderson JL, Lewin SR, Purcell DFJ (2018) HIV latency reversing agents act through Tat post translational modifications. Retrovirology 15(1)
Kim M, Siliciano RF (2016) Reservoir expansion by T-cell proliferation may be another barrier to curing HIV infection. Proc Natl Acad Sci U S A 113(7):1692–1694. https://doi.org/10.1073/pnas.1600097113
Klase Z, Kale P, Winograd R, Gupta MV, Heydarian M, Berro R, McCaffrey T, Kashanchi F (2007) HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol Biol 8:63
Klase Z, Winograd R, Davis J, Carpio L, Hildreth R, Heydarian M, Fu S, McCaffrey T, Meiri E, Ayash-Rashkovsky M, Gilad S, Bentwich Z, Kashanchi F (2009) HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6:18
Kula A, Guerra J, Knezevich A, Kleva D, Myers MP, Marcello A (2011) Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of rev function. Retrovirology 8:60
Kula A, Gharu L, Marcello A (2012) HIV-1 pre-mRNA commitment to rev mediated export through PSF and Matrin 3. Virology
Lamond AI, Sleeman JE (2003) Nuclear substructure and dynamics. Curr Biol 13(21):R825–R828
Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF (2006) Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog 2(7):650–661
Lelek M, Casartelli N, Pellin D, Rizzi E, Souque P, Severgnini M, Di Serio C, Fricke T, Diaz-Griffero F, Zimmer C, Charneau P, Di Nunzio F (2015) Chromatin organization at the nuclear pore favours HIV replication. Nat Commun 6:6483. https://doi.org/10.1038/ncomms7483
Lenasi T, Peterlin BM, Barboric M (2011) Cap-binding protein complex links pre-mRNA capping to transcription elongation and alternative splicing through positive transcription elongation factor b (P-TEFb). J Biol Chem 286(26):22758–22768. https://doi.org/10.1074/jbc.M111.235077
Lewinski MK, Bisgrove D, Shinn P, Chen H, Hoffmann C, Hannenhalli S, Verdin E, Berry CC, Ecker JR, Bushman FD (2005) Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79(11):6610–6619. https://doi.org/10.1128/JVI.79.11.6610-6619.2005
Li J, Chen C, Ma X, Geng G, Liu B, Zhang Y, Zhang S, Zhong F, Liu C, Yin Y, Cai W, Zhang H (2016) Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation. Nat Commun 7:11730. https://doi.org/10.1038/ncomms11730
Lusic M, Marini B, Ali H, Lucic B, Luzzati R, Giacca M (2013) Proximity to PML nuclear bodies regulates HIV-1 latency in CD4+ T cells. Cell Host Microbe 13(6):665–677. https://doi.org/10.1016/j.chom.2013.05.006
Mahmoudi T (2012) The BAF complex and HIV latency. Transcription 3(4):171–176. https://doi.org/10.4161/trns.20541
Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, Coffin JM, Hughes SH (2014) HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 345(6193):179–183. https://doi.org/10.1126/science.1254194
Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26(2):412–423. https://doi.org/10.1038/sj.emboj.7601516
Marcello A, Ferrari A, Pellegrini V, Pegoraro G, Lusic M, Beltram F, Giacca M (2003) Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein. EMBO J 22(9):2156–2166. https://doi.org/10.1093/emboj/cdg205
Marini B, Kertesz-Farkas A, Ali H, Lucic B, Lisek K, Manganaro L, Pongor S, Luzzati R, Recchia A, Mavilio F, Giacca M, Lusic M (2015) Nuclear architecture dictates HIV-1 integration site selection. Nature 521(7551):227–231. https://doi.org/10.1038/nature14226
Mbonye UR, Wang B, Gokulrangan G, Chance MR, Karn J (2015) Phosphorylation of HEXIM1 at Tyr271 and Tyr274 promotes release of P-TEFb from the 7SK snRNP complex and enhances Proviral HIV gene expression. Proteomics 15(12):2078–2086. https://doi.org/10.1002/pmic.201500038
Misteli T (2007) Beyond the sequence: cellular organization of genome function. Cell 128(4):787–800. https://doi.org/10.1016/j.cell.2007.01.028
Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM (2009) Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol Cell 34(6):696–709. https://doi.org/10.1016/j.molcel.2009.06.003
Ocwieja KE, Sherrill-Mix S, Mukherjee R, Custers-Allen R, David P, Brown M, Wang S, Link DR, Olson J, Travers K, Schadt E, Bushman FD (2012) Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res 40(20):10345–10355. https://doi.org/10.1093/nar/gks753
Omoto S, Ito M, Tsutsumi Y, Ichikawa Y, Okuyama H, Brisibe EA, Saksena NK, Fujii YR (2004) HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1:44
Ouellet DL, Plante I, Landry P, Barat C, Janelle ME, Flamand L, Tremblay MJ, Provost P (2008) Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res 36(7):2353–2365
Pan XY, Zhao W, Zeng XY, Lin J, Li MM, Shen XT, Liu SW (2016) Heat shock factor 1 mediates latent HIV reactivation. Sci Rep 6:26294. https://doi.org/10.1038/srep26294
Perkins ND, Felzien LK, Betts JC, Leung K, Beach DH, Nabel GJ (1997) Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275(5299):523–527
Purcell DFJ, Martin MA (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67(11):6365–6378
Qian S, Zhong X, Yu L, Ding B, de Haan P, Boris-Lawrie K (2009) HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc Natl Acad Sci U S A 106 (2):605–610
Ruelas DS, Chan JK, Oh E, Heidersbach AJ, Hebbeler AM, Chavez L, Verdin E, Rape M, Greene WC (2015) MicroRNA-155 reinforces HIV latency. J Biol Chem 290(22):13736–13748. https://doi.org/10.1074/jbc.M115.641837
Schopman NC, Willemsen M, Liu YP, Bradley T, van Kampen A, Baas F, Berkhout B, Haasnoot J (2012) Deep sequencing of virus-infected cells reveals HIV-encoded small RNAs. Nucleic Acids Res 40(1):414–427
Schrijvers R, De Rijck J, Demeulemeester J, Adachi N, Vets S, Ronen K, Christ F, Bushman FD, Debyser Z, Gijsbers R (2012) LEDGF/p75-independent HIV-1 replication demonstrates a role for HRP-2 and remains sensitive to inhibition by LEDGINs. PLoS Pathog 8(3):e1002558. https://doi.org/10.1371/journal.ppat.1002558
Shan L, Yang HC, Rabi SA, Bravo HC, Shroff NS, Irizarry RA, Zhang H, Margolick JB, Siliciano JD, Siliciano RF (2011) Influence of host gene transcription level and orientation on HIV-1 latency in a primary-cell model. J Virol 85(11):5384–5393. https://doi.org/10.1128/JVI.02536-10
Sherrill-Mix S, Lewinski MK, Famiglietti M, Bosque A, Malani N, Ocwieja KE, Berry CC, Looney D, Shan L, Agosto LM, Pace MJ, Siliciano RF, O’Doherty U, Guatelli J, Planelles V, Bushman FD (2013) HIV latency and integration site placement in five cell-based models. Retrovirology 10:90. https://doi.org/10.1186/1742-4690-10-90
Simonetti FR, Sobolewski MD, Fyne E, Shao W, Spindler J, Hattori J, Anderson EM, Watters SA, Hill S, Wu X, Wells D, Su L, Luke BT, Halvas EK, Besson G, Penrose KJ, Yang Z, Kwan RW, Van Waes C, Uldrick T, Citrin DE, Kovacs J, Polis MA, Rehm CA, Gorelick R, Piatak M, Keele BF, Kearney MF, Coffin JM, Hughes SH, Mellors JW, Maldarelli F (2016) Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo. Proc Natl Acad Sci U S A 113(7):1883–1888. https://doi.org/10.1073/pnas.1522675113
Sobhian B, Laguette N, Yatim A, Nakamura M, Levy Y, Kiernan R, Benkirane M (2010) HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell 38(3):439–451. https://doi.org/10.1016/j.molcel.2010.04.012
Sowd GA, Serrao E, Wang H, Wang W, Fadel HJ, Poeschla EM, Engelman AN (2016) A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin. Proc Natl Acad Sci U S A 113(8):E1054–E1063. https://doi.org/10.1073/pnas.1524213113
Sung TL, Rice AP (2006) Effects of prostratin on cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Retrovirology 3:66. https://doi.org/10.1186/1742-4690-3-66
Sung TL, Rice AP (2009) miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 5(1):e1000263. https://doi.org/10.1371/journal.ppat.1000263
Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9(6):465–476. https://doi.org/10.1038/nrg2341
Trejbalova K, Kovarova D, Blazkova J, Machala L, Jilich D, Weber J, Kucerova D, Vencalek O, Hirsch I, Hejnar J (2016) Development of 5′ LTR DNA methylation of latent HIV-1 provirus in cell line models and in long-term-infected individuals. Clin Epigenetics 8:19. https://doi.org/10.1186/s13148-016-0185-6
Triboulet R, Mari B, Lin Y-L, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M (2007) Suppression of MicroRNA-silencing pathway by HIV-1 during virus replication. Science 315(5818):1579–1582
Tripathi V, Ellis JD, Shen Z, Song DY, Pan Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, Blencowe BJ, Prasanth SG, Prasanth KV (2010) The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol Cell 39(6):925–938. https://doi.org/10.1016/j.molcel.2010.08.011
Van Lint C, Burny A, Verdin E (1991) The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J Virol 65(12):7066–7072
Van Lint C, Ghysdael J, Paras P Jr, Burny A, Verdin E (1994) A transcriptional regulatory element is associated with a nuclease-hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol 68(4):2632–2648
Van Lint C, Emiliani S, Ott M, Verdin E (1996) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J 15(5):1112–1120
Van Lint C, Amella CA, Emiliani S, John M, Jie T, Verdin E (1997) Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J Virol 71(8):6113–6127
Van Lint C, Bouchat S, Marcello A (2013) HIV-1 transcription and latency: an update. Retrovirology 10:67. https://doi.org/10.1186/1742-4690-10-67
Verdin E, Paras P, Jr., Van Lint C (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J 12 (8):3249–3259
Viré E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, Bollen M, Esteller M, Di Croce L, De Launoit Y, Fuks F (2006) The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439(7078):871–874. https://doi.org/10.1038/nature04431
Wagner TA, McLaughlin S, Garg K, Cheung CY, Larsen BB, Styrchak S, Huang HC, Edlefsen PT, Mullins JI, Frenkel LM (2014) HIV latency. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection. Science 345(6196):570–573. https://doi.org/10.1126/science.1256304
Wagschal A, Rousset E, Basavarajaiah P, Contreras X, Harwig A, Laurent-Chabalier S, Nakamura M, Chen X, Zhang K, Meziane O, Boyer F, Parrinello H, Berkhout B, Terzian C, Benkirane M, Kiernan R (2012) Microprocessor, Setx, Xrn2, and Rrp6 co-operate to induce premature termination of transcription by RNAPII. Cell 150(6):1147–1157. https://doi.org/10.1016/j.cell.2012.08.004
Witwer KW, Watson AK, Blankson JN, Clements JE (2012) Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 9:5
Wong RW, Mamede JI, Hope TJ (2015) Impact of nucleoporin-mediated chromatin localization and nuclear architecture on HIV integration site selection. J Virol 89(19):9702–9705. https://doi.org/10.1128/JVI.01669-15
Yang G, Thompson MA, Brandt SJ, Hiebert SW (2007) Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein. Oncogene 26(1):91–101. https://doi.org/10.1038/sj.onc.1209760
Yedavalli VS, Jeang KT (2011) Matrin 3 is a co-factor for HIV-1 rev in regulating post-transcriptional viral gene expression. Retrovirology 8:61. https://doi.org/10.1186/1742-4690-8-61
Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, Jeang KT (2009) Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res 37(19):6575–6586
Zhang HS, Chen XY, Wu TC, Sang WW, Ruan Z (2012a) MiR-34a is involved in tat-induced HIV-1 long terminal repeat (LTR) transactivation through the SIRT1/NFkappaB pathway. FEBS Lett 586(23):4203–4207. https://doi.org/10.1016/j.febslet.2012.10.023
Zhang HS, Wu TC, Sang WW, Ruan Z (2012b) MiR-217 is involved in Tat-induced HIV-1 long terminal repeat (LTR) transactivation by down-regulation of SIRT1. Biochim Biophys Acta 1823(5):1017–1023. https://doi.org/10.1016/j.bbamcr.2012.02.014
Zhang Q, Chen CY, Yedavalli VS, Jeang KT (2013) NEAT1 long noncoding RNA and paraspeckle bodies modulate HIV-1 posttranscriptional expression. MBio 4(1):e00596-00512. https://doi.org/10.1128/mBio.00596-12
Zolotukhin AS, Michalowski D, Bear J, Smulevitch SV, Traish AM, Peng R, Patton J, Shatsky IN, Felber BK (2003) PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression. Mol Cell Biol 23(18):6618–6630. https://doi.org/10.1128/MCB.23.18.6618-6630.2003
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Khoury, G. et al. (2018). The Molecular Biology of HIV Latency. In: Zhang, L., Lewin, S. (eds) HIV Vaccines and Cure . Advances in Experimental Medicine and Biology, vol 1075. Springer, Singapore. https://doi.org/10.1007/978-981-13-0484-2_8
Download citation
DOI: https://doi.org/10.1007/978-981-13-0484-2_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0483-5
Online ISBN: 978-981-13-0484-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)